NIH Would ‘Revolutionize’ Cancer Trial Recruitment With New ‘Moonshot’ Money

 
• By Sarah Karlin-Smith
  
diversity of faces
A Cancer Moonshot budget boost for NIH could aid FDA’s trial diversity efforts. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D